Dr. Qing Zhou
Designation: Associate Research Scientist
Department: Department of pathology and cell biology
Email: qz2266@cumc.columbia.edu
University: Columbia University
Country: United States
Dr. Qing Zhou obtained her Ph.D. in Pharmacology from Tsinghua University in China, where her research on cancer drug resistance earned her the degree. After completing her doctorate, she pursued postdoctoral training at Washington State University, focusing on the maintenance of telomeres and genome integrity in cancer. Dr. Zhou currently serves as an Associate Research Scientist in the Department of Pathology and Cell Biology at Columbia University Medical Center, where she is dedicated to developing novel strategies that target transcription factors for treating cancer.
Dr. Zhou has actively participated in cancer research at regional, national, and international levels. Her vast experience includes identifying innovative anti-cancer therapeutics and investigating their mechanisms at the preclinical stage. She is mainly interested in discovering and translating promising drug regimens into clinical practice to help cancer patients fight the disease.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
